Pay ₹0 for 75 days of Genius, On India's 75 years of Independence by signing up within 75 hours
Download Mobile Apps

Great! You have sucessfully subscribed for newsletters for investments

Subscribed email:


NAV as of ( Sep 09, 2022 )

18.29 -0.14 % 1-D Change

9.36% p.a.

You get upto 1.51% extra returns

ET Money's Fund Report Card - Tata India Pharma & HealthCare Fund

ET Money Rank

not ranking

Not yet ranked

Performance Quality info

Good drop-arrow

Generated returns consistently


Increased returns for each unit of additional risk info


Downside Protection info

Very Good drop-arrow

Controlled losses during market corrections


Delivered returns without frequent ups and downs


Minimum SIP amount is ₹
Minimum Lumpsum amount is ₹

By continuing, I agree to the Declaration and T&Cs.

none buyable frame

Fresh Investments closed in this fund!

This fund is no longer available to invest

This fund vs
Show performance of:

Scheme Details

ET Money Rank Not yet ranked
VRO Rating N.A.
Expense ratio 0.99%  As on Jul 31, 2022
Exit Load 0.25% info
AUM (Fund Size) 519 Crs
Lock-in No Lockin
Age 6 yrs 9 m Since Dec 04, 2015
Benchmark Nifty Pharma_Adj
Min. Investment

SIP 500  &

Lumpsum 5000

About Tata India Pharma & HealthCare Fund

Tata India Pharma & HealthCare Fund Direct-Growth is a Sectoral-Pharma mutual fund scheme from Tata Mutual Fund . This fund has been in existence for 6 yrs 9 m, having been launched on 04/12/2015. Tata India Pharma & HealthCare Fund Direct-Growth has ₹519 Crores worth of assets under management (AUM) as on 30/06/2022 and is medium-sized fund of its category. The fund has an expense ratio of 0.99%, which is close to what most other Sectoral-pharma funds charge.
  • Tata India Pharma & HealthCare Fund Direct-Growth returns of last 1-year are -7.84%. Since launch, it has delivered 9.42% average annual returns. The fund has doubled the money invested in it every 3 yrs.
  • Tata India Pharma & HealthCare Fund Direct-Growth scheme's ability to deliver returns consistently is in-line with most funds of its category. Its ability to control losses in a falling market is above average.
  • The fund has the majority of its money invested in Healthcare, Insurance sectors. It has taken less exposure in Healthcare, Insurance sectors compared to other funds in the category.
  • The fund's top 5 holdings are in Sun Pharmaceutical Inds. Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Apollo Hospitals Enterprise Ltd., Alkem Laboratories Ltd..
Find your investor personality!

Answer a few simple questions and understand why you take the financial decisions you do.

Investment Returns Calculator

of for

You would have earned ₹ 1,001 more by investing in ET Money Direct Plan

Total value Profit
This fund
Category Average
Bank FD

Disclaimer: Products compared like fixed deposits may provide fixed guaranteed returns. Mutual Funds investments are subject to market risk, read all scheme related documents carefully. Past performance is not an indicator of future returns.

Latest Asset & Portfolio Allocation

as on Aug 31, 2022
Allocation by Market Cap

Large Cap 52.67%

Mid Cap 26.66%

Small Cap 19.83%

Other Cap 0%

Allocation by Sector

Healthcare 98.04%

Insurance 1.12%

Top Debt Holdings

Bifurcation by Holding is not available for this fund

Allocation by Credit Quality

Bifurcation by Credit Quality is not available for this fund

Allocation by Instruments

Repo 1.41%

Other Holdings

Others 1.41%

Know in detail about the portfolio of this fund See detailed Portfolio Analysis

Comparison with sectoral-pharma Funds

as on Sep 12, 2022
0.04 % p.a
This fund


Pick time period to see return
  • 1m
  • 3m
  • 6m
  • 1y
  • 3y
  • 5y
Fund name Annual Return % Consistency Value Research Rating
Nippon India Pharma Fund 18.29%
Tata India Pharma & HealthCare Fund 16.85%
UTI Healthcare Fund 13.95%
SBI Healthcare Opportunities Fund 13.45%

Trailing Returns and Ranks

as on Sep 12, 2022
Period Trailing returns Category average Rank within category
1 month 0.04% 0.53% 6 / 8
3 months 7.3% 7.78% 5 / 8
6 months -2.35% -1.62% 6 / 8
1 year -8.42% -9.71% 3 / 8
3 years 24.11% 25.82% 7 / 8
5 years 16.85% 15.64% 2 / 4

Know in detail about the returns of this fund See detailed Return Analysis


Level of Risk in the Scheme

Very High

Investors understand that their principal will be at Very High risk

Tata India Pharma & HealthCare Fund


The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

  • Std. Dev : 19.0
  • Alpha : 4.74
  • Beta : 0.82
  • Sharpe : 1.07
  • Sortino : 2.4
  • Profile

    Meeta Shetty

    Ms. Shetty is Bachelor in Economics and CFA Charterholder

    Prior to joining TATA Mutual Fund, she has worked with Kotak Securities, HDFC Securities, AMSEC(Asian Market Securities), Dalal & Broacha Stock Broking and karvey Stock Broking.

Tata Mutual Fund

Tata Mutual Fund



See all schemes


₹88,392 Crs

As on Jun 30, 2022

  • Email:
  • Phone: 1800-209-0101
  • Address: 9th Floor, Mafatlal Centre,
    Nariman Point,

    Mumbai, 400021

Compare with similar Funds

Hide comparison

Frequently asked questions

How are the returns of Tata India Pharma & HealthCare Fund ?

The Tata India Pharma & HealthCare Fund is a 6 yrs 9 m old fund and has delivered average annual returns of 9.36% since inception.

Tata India Pharma & HealthCare Fund Returns

1-Year 3-Year 5-Year Since Inception
-8.42% 24.11% 16.85% 9.36%

NAV or Net Asset Value is the per-unit price of the Mutual Fund. The NAV of a Mutual Fund changes every day. It is calculated by taking the current value of the holdings of the fund at end of the day, subtracting the expenses, and dividing the value by the number of units issued to date.

The NAV of Tata India Pharma & HealthCare Fund for Sep 09, 2022 is 18.29 .

On ET Money, Investing in Tata India Pharma & HealthCare Fund is fast, easy, and 100% paperless. And it takes only minutes. Here is what you need to do -

  1. Click on the Invest Now Button present on the top right-hand side.
  2. Enter your email id, select whether you want to do a one-time investment or start a SIP and add the amount
  3. Provide few more details needed including the bank account from which you will be making the payment and confirm.
  4. That's it. Your SIP or one-time investment in Tata India Pharma & HealthCare Fund is done.

The Expense Ratio of a Mutual Fund is the annual charges you pay to the Mutual Fund company for managing your investments in that fund. The Expense Ratio is a percentage of Assets Under Management (AUM) and is taken from the returns generated by the fund. For this reason, a fund with a lower expense ratio is always better because a smaller part of the returns will be taken and that means more returns for you.

The Expense Ratio of the direct plan of Tata India Pharma & HealthCare Fund is 0.99%.  .

Redeeming your investments in Tata India Pharma & HealthCare Fund is super easy. If you have invested in this fund via ET Money, just login into the app, go to the investment section and put the redemption request.

If you have invested in Tata India Pharma & HealthCare Fund from anywhere else, you can go to the fund house website and put a request through it.

AUM or Asset Under Management is the total value of the assets held by a Mutual Fund scheme. For instance, for an equity Mutual Fund, the AUM will be the total value of its portfolio's equity shares (plus any other asset it might have invested in). The AUM of the fund changes every day because the price of the underlying asset fluctuates daily. However, the Mutual Fund company doesn't update it every day. It is updated only at the end of the month and released within few days of the next month.

The AUM of the fund is a good indicator of its popularity. A fund with a high AUM means a lot of money has been invested in it, and investors like it. However, the AUM should never be the primary criteria while selecting a fund. There are funds with huge AUMs that continue to perform well despite their size.

The AUM of Tata India Pharma & HealthCare Fund is ₹519 Crs.

The Tata India Pharma & HealthCare Fund has invested the majority of its money in the stocks of the following companies -

Company Percentage of Portfolio
Sun Pharmaceutical Inds. Ltd. 15.69%
Dr. Reddy's Laboratories Ltd. 12.36%
Cipla Ltd. 12.1%
Apollo Hospitals Enterprise Ltd. 7.02%
Alkem Laboratories Ltd. 5.91%
Fortis Healthcare (India) Ltd 5.7%
Ipca Laboratories Ltd. 5.54%
Lupin Ltd. 4.16%
JB Chemicals & Pharmaceuticals Ltd. 3.54%
Aurobindo Pharma Ltd. 2.68%

The Tata India Pharma & HealthCare Fund has primarily invested in the following sectors

Sector Percentage of Portfolio
Healthcare 98.04%
Insurance 1.12%
亚博电竞 csgo 日博电竞外围全球9.4.2 dota2投注线上 lpl电竞比分注册APP v2.6(lpl电竞选手下载v3.1版) JJ竞技(拉萨)登录手游